- TheStreet.com•8 days ago
Threshold Pharma (THLD) stock is advancing on Monday afternoon alongside other biopharma stocks as fellow drug maker Medivation (MDVN) agreed to be bought by Pfizer (PFE) for $14 billion.
- Associated Press•last month
The South San Francisco, California-based company said it had a loss of 10 cents per share. The company's shares closed at 51 cents. A year ago, they were trading at $4.26. _____ This story was generated ...
- GlobeNewswire•last month
--Presented additional subset data at ASCO from Phase 3 MAESTRO trial of evofosfamide in pancreatic cancer; meaningful improvement in overall survival in patients from Asia--. SOUTH SAN FRANCISCO, Calif., ...
Threshold Pharmaceuticals Inc. (THLD)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||1.07 x 200|
|Ask||1.10 x 2000|
|Day's Range||1.00 - 1.12|
|52wk Range||0.21 - 5.28|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||1.79|
|Avg Vol (3m)||2,405,350|
|Dividend & Yield||N/A (N/A)|